Description

Trading in equity shares of MAHAMAYA LIFESCIENCES LIMITED will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective December 1, 2025.

Summary

BSE has announced that the equity shares of MAHAMAYA LIFESCIENCES LIMITED (Scrip Code: 544611), currently listed on the SME platform, will be transferred from the Trade for Trade segment (MT Group) to the Rolling segment (M Group) effective December 1, 2025. This change follows the company’s SME IPO listing and represents a transition to normal trading operations.

Key Points

  • Company: MAHAMAYA LIFESCIENCES LIMITED (SME IPO)
  • Scrip Code: 544611
  • Current Group: MT Group (Trade for Trade segment)
  • New Group: M Group (Rolling segment)
  • Effective Date: Monday, December 1, 2025
  • Notice Number: 20251118-5
  • Contact: Mr. Anurag Jain, Tel: 022-2272 8822

Regulatory Changes

The equity shares will transition from the restrictive Trade for Trade (T2T) segment to the Rolling settlement segment. This change allows for:

  • Normal intraday trading (previously restricted in T2T)
  • Standard settlement cycles instead of compulsory delivery-based trading
  • Improved liquidity and trading flexibility

Compliance Requirements

Trading members should:

  • Note the change in trading segment effective December 1, 2025
  • Update their systems to reflect the new group classification (M Group)
  • Contact Mr. Anurag Jain for any clarifications or technical details
  • Refer to continuation notice 20251117-58 dated November 17, 2025 for background

Important Dates

  • November 17, 2025: Initial notice issued (Notice No. 20251117-58)
  • November 18, 2025: Current notice date
  • December 1, 2025: Effective date for segment transfer from MT to M Group

Impact Assessment

Market Impact: Medium - The transition from Trade for Trade to Rolling segment typically increases liquidity and trading volumes as it removes delivery restrictions. This is positive for existing shareholders and potential investors.

Trading Impact: The change enables intraday trading and standard settlement mechanisms, making the stock more accessible to retail and institutional traders. Previously, T2T segment requires 100% upfront margin and compulsory delivery, which limits trading activity.

Investor Impact: Existing shareholders will benefit from improved liquidity and easier exit options. The stock becomes eligible for margin trading and other normal market mechanisms available in the Rolling segment.

Impact Justification

Routine segment transfer for SME IPO from restrictive Trade for Trade to normal Rolling segment, affecting trading flexibility for existing shareholders